The Research and Development team at Tarsier Pharma focuses on advancing innovative treatments for autoimmune and inflammatory ocular diseases. Led by the Head of Chemistry, they collaborate on drug formulation, conduct preclinical studies, and oversee clinical trial designs to ensure safety and efficacy. Their interdisciplinary expertise drives the development pipeline from initial concept through late-stage clinical trials.
View all